Food and Drug Administration (FDA), Thailand and Pharmaceutical and Medical Device Agency (PMDA), Japan recently convened for a bilateral meeting, aiming to enhance regulatory systems for pharmaceuticals and medical devices. This collaboration aspires to ensure that citizens have access pharmaceuticals which are high-quality, effective and safe and recognized internationally, as well as to facilitate Thailand’s access to innovative medical devices.
On January 17, 2024, the Thai FDA, together with PMDA, organized the Thailand-Japan Bilateral Meeting at Hotel Nikko Bangkok. Dr. Narong Aphikulvanich, Secretary-General of the Thai FDA, highlighted that the meeting focused on in-depth information exchange and experiences in various areas including clinical drug regulations and research, regulation of remanufactured medical devices, regulation of quasi-drugs, drug registration using PMDA's assessment reports, medical device registration referencing regulatory authorities recognized by the Thai FDA and consultation systems. The conclusions from this meeting will be utilized to develop regulatory systems and personnel training for evaluating pharmaceuticals and medical devices dossier, ultimately ensuring public access to high-quality, effective, and safe medications and advanced medical devices, while responding to emerging health challenges and maximizing public benefits.
Dr. Narong stated about the longstanding relationship between Thailand and Japan, emphasizing that the discussions offered a great opportunity to expand academic cooperation for the efficient and effective regulation of pharmaceuticals and medical devices, benefitting both nations.
